Find Prednicarbate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

Annual Reports

NA

29 RELATED EXCIPIENT COMPANIES

47EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Dermatop, 73771-04-7, Hoe 777, Hoe-777, Dermatop e emollient, S-770777
Molecular Formula
C27H36O8
Molecular Weight
488.6  g/mol
InChI Key
FNPXMHRZILFCKX-KAJVQRHHSA-N
FDA UNII
V901LV1K7D

Prednicarbate
Prednicarbate is a synthetic non-halogenated double-ester derivative of the corticosteroid prednisolone with anti-inflammatory, antipruritic and vasoconstrictive properties. Following skin permeation, prednicarbate enters cells and binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of pro-inflammatory cytokine production by increasing the expression of lipocortins. These block phospholipase A-dependent release of arachidonic acid thereby inhibiting prostaglandin synthesis. This agent also decreases the number of circulating lymphocytes by suppression of the production of vasodilators such as prostacyclin and nitric oxide.
Prednicarbate is a Corticosteroid. The mechanism of action of prednicarbate is as a Corticosteroid Hormone Receptor Agonist.
1 2D Structure

Prednicarbate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2.1.2 InChI
InChI=1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1
2.1.3 InChI Key
FNPXMHRZILFCKX-KAJVQRHHSA-N
2.1.4 Canonical SMILES
CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC
2.1.5 Isomeric SMILES
CCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C)OC(=O)OCC
2.2 Other Identifiers
2.2.1 UNII
V901LV1K7D
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Batmen

2. Dermatop

3. Hoe 777

4. Hoe-777

5. Peitel

6. Prednisolone-17-ethylcarbonate-21-propionate

2.3.2 Depositor-Supplied Synonyms

1. Dermatop

2. 73771-04-7

3. Hoe 777

4. Hoe-777

5. Dermatop E Emollient

6. S-770777

7. Mls002154121

8. V901lv1k7d

9. Las189961

10. S 77 0777

11. S-77 0777

12. Las-189961

13. Nsc-760042

14. Peitel

15. Las-41003 Component Prednicarbate

16. Unii-v901lv1k7d

17. S-77-0777

18. Prednicarbato

19. Prednicarbatum

20. [2-[(8s,9s,10r,11s,13s,14s,17r)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Propanoate

21. Dermatop (tn)

22. Prednicarbate (usp/inn)

23. Prednicarbatum [inn-latin]

24. Prednicarbat

25. Prednicarbato [inn-spanish]

26. Ncgc00016926-01

27. Einecs 277-590-3

28. Prednicarbate [usan:usp:inn:ban]

29. Cas-73771-04-7

30. Prestwick0_001044

31. Prestwick1_001044

32. Prestwick2_001044

33. Prestwick3_001044

34. Prednicarbate [mi]

35. Prednicarbate [inn]

36. Schembl3941

37. Dsstox_cid_25502

38. Dsstox_rid_80919

39. Prednicarbate [usan]

40. Dsstox_gsid_45502

41. Bspbio_000968

42. Prednicarbate [vandf]

43. Prednicarbate [mart.]

44. S 770777

45. Spbio_002904

46. Prednicarbate [usp-rs]

47. Prednicarbate [who-dd]

48. Bpbio1_001066

49. Gtpl7605

50. Chembl1200386

51. Dtxsid9045502

52. Chebi:135791

53. Hms1571a10

54. Hms2098a10

55. Hms2230o11

56. Hms3715a10

57. Prednicarbate [orange Book]

58. Hy-b1365

59. Zinc3938652

60. Prednicarbate [ep Monograph]

61. Tox21_110687

62. Prednicarbate [usp Monograph]

63. Akos025402043

64. Prednicarbate For System Suitability A

65. Ac-3521

66. Ccg-221044

67. Db01130

68. Nsc 760042

69. 11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17-(ethyl Carbonate) 21-propionate

70. Ncgc00179357-01

71. Ncgc00179357-05

72. Pregna-1,4-diene-3,20-dione, 17-((ethoxycarbonyl)oxy)-11-hydroxy-21-(1-oxopropoxy)-, (11beta)-

73. Smr001233428

74. Ab00514017

75. Cs-0013106

76. D05601

77. 771p047

78. Sr-01000841201

79. Q-101379

80. Q4376623

81. Sr-01000841201-2

82. Brd-k46137903-001-03-3

83. 11.beta.,17,21-trihydroxypregna-1,4-diene-3,20-dione 17-(ethyl Carbonate) 21-propionate

84. Pregna-1,4-diene-3,20-dione, 17-((ethoxycarbonyl)oxy)-11-hydroxy-21-(1-oxopropoxy)-, (11.beta.)-

2.4 Create Date
2006-06-05
3 Chemical and Physical Properties
Molecular Weight 488.6 g/mol
Molecular Formula C27H36O8
XLogP34.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count9
Exact Mass488.24101810 g/mol
Monoisotopic Mass488.24101810 g/mol
Topological Polar Surface Area116 Ų
Heavy Atom Count35
Formal Charge0
Complexity982
Isotope Atom Count0
Defined Atom Stereocenter Count7
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameDermatop
PubMed HealthPrednicarbate (Topical application route)
Drug ClassesAdrenal Glucocorticoid, Corticosteroid, Intermediate
Drug LabelDERMATOP Ointment (prednicarbate ointment) 0.1% contains the non-halogenated prednisolone derivative prednicarbate. The topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic...
Active IngredientPrednicarbate
Dosage FormOintment
RouteTopical
Strength0.1%
Market StatusPrescription
CompanyValeant Bermuda

2 of 6  
Drug NameDermatop e emollient
PubMed HealthPrednicarbate (Topical application route)
Drug ClassesAdrenal Glucocorticoid, Corticosteroid, Intermediate
Drug LabelDERMATOP Ointment (prednicarbate ointment) 0.1% contains the non-halogenated prednisolone derivative prednicarbate. The topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic...
Active IngredientPrednicarbate
Dosage FormCream
RouteTopical
Strength0.1%
Market StatusPrescription
CompanyValeant Bermuda

3 of 6  
Drug NamePrednicarbate
Active IngredientPrednicarbate
Dosage FormOintment; Cream
RouteTopical
Strength0.1%
Market StatusPrescription
CompanyFougera Pharms

4 of 6  
Drug NameDermatop
PubMed HealthPrednicarbate (Topical application route)
Drug ClassesAdrenal Glucocorticoid, Corticosteroid, Intermediate
Drug LabelDERMATOP Ointment (prednicarbate ointment) 0.1% contains the non-halogenated prednisolone derivative prednicarbate. The topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic...
Active IngredientPrednicarbate
Dosage FormOintment
RouteTopical
Strength0.1%
Market StatusPrescription
CompanyValeant Bermuda

5 of 6  
Drug NameDermatop e emollient
PubMed HealthPrednicarbate (Topical application route)
Drug ClassesAdrenal Glucocorticoid, Corticosteroid, Intermediate
Drug LabelDERMATOP Ointment (prednicarbate ointment) 0.1% contains the non-halogenated prednisolone derivative prednicarbate. The topical corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic...
Active IngredientPrednicarbate
Dosage FormCream
RouteTopical
Strength0.1%
Market StatusPrescription
CompanyValeant Bermuda

6 of 6  
Drug NamePrednicarbate
Active IngredientPrednicarbate
Dosage FormOintment; Cream
RouteTopical
Strength0.1%
Market StatusPrescription
CompanyFougera Pharms

4.2 Drug Indication

For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Corticosteroids diffuse across cell membranes and complex with specific cytoplasmic receptors. These complexes then enter the cell nucleus, bind to DNA (chromatin), and stimulate transcription of messenger RNA (mRNA) and subsequent protein synthesis of various inhibitory enzymes responsible for the anti-inflammatory effects of topical corticosteroids. These anti-inflammatory effects include inhibition of early processes such as edema, fibrin deposition, capillary dilatation, movement of phagocytes into the area, and phagocytic activities. Later processes, such as capillary production, collagen deposition, and keloid formation also are inhibited by corticosteroids.


5.2 MeSH Pharmacological Classification

Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


Glucocorticoids

A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
PREDNICARBATE
5.3.2 FDA UNII
V901LV1K7D
5.3.3 Pharmacological Classes
Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]
5.4 ATC Code

D - Dermatologicals

D07 - Corticosteroids, dermatological preparations

D07A - Corticosteroids, plain

D07AC - Corticosteroids, potent (group iii)

D07AC18 - Prednicarbate


5.5 Absorption, Distribution and Excretion

Absorption

Absorbed systemically across the stratum corneum.


5.6 Metabolism/Metabolites

Primarily in skin


5.7 Mechanism of Action

In common with other topical corticosteroids, prednicarbate has anti-inflammatory, antipruritic, and vasoconstrictive properties. In general, the mechanism of the anti-inflammatory activity of topical steroids is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - OINTMENT;TOPICAL - 0.1% **Federal Re...DOSAGE - OINTMENT;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19568

read-more

DOSAGE - CREAM;TOPICAL - 0.1% **Federal Regis...DOSAGE - CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20279

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Solubilizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Direct Compression

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Controlled & Modified Release

read-more
read-more

Parenteral

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Prednicarbate Manufacturers

A Prednicarbate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prednicarbate, including repackagers and relabelers. The FDA regulates Prednicarbate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prednicarbate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Prednicarbate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Prednicarbate Suppliers

A Prednicarbate supplier is an individual or a company that provides Prednicarbate active pharmaceutical ingredient (API) or Prednicarbate finished formulations upon request. The Prednicarbate suppliers may include Prednicarbate API manufacturers, exporters, distributors and traders.

click here to find a list of Prednicarbate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Prednicarbate USDMF

A Prednicarbate DMF (Drug Master File) is a document detailing the whole manufacturing process of Prednicarbate active pharmaceutical ingredient (API) in detail. Different forms of Prednicarbate DMFs exist exist since differing nations have different regulations, such as Prednicarbate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Prednicarbate DMF submitted to regulatory agencies in the US is known as a USDMF. Prednicarbate USDMF includes data on Prednicarbate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prednicarbate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Prednicarbate suppliers with USDMF on PharmaCompass.

Prednicarbate KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Prednicarbate Drug Master File in Korea (Prednicarbate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Prednicarbate. The MFDS reviews the Prednicarbate KDMF as part of the drug registration process and uses the information provided in the Prednicarbate KDMF to evaluate the safety and efficacy of the drug.

After submitting a Prednicarbate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Prednicarbate API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Prednicarbate suppliers with KDMF on PharmaCompass.

Prednicarbate CEP

A Prednicarbate CEP of the European Pharmacopoeia monograph is often referred to as a Prednicarbate Certificate of Suitability (COS). The purpose of a Prednicarbate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Prednicarbate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Prednicarbate to their clients by showing that a Prednicarbate CEP has been issued for it. The manufacturer submits a Prednicarbate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Prednicarbate CEP holder for the record. Additionally, the data presented in the Prednicarbate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Prednicarbate DMF.

A Prednicarbate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Prednicarbate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Prednicarbate suppliers with CEP (COS) on PharmaCompass.

Prednicarbate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prednicarbate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Prednicarbate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Prednicarbate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Prednicarbate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prednicarbate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Prednicarbate suppliers with NDC on PharmaCompass.

Prednicarbate GMP

Prednicarbate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Prednicarbate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prednicarbate GMP manufacturer or Prednicarbate GMP API supplier for your needs.

Prednicarbate CoA

A Prednicarbate CoA (Certificate of Analysis) is a formal document that attests to Prednicarbate's compliance with Prednicarbate specifications and serves as a tool for batch-level quality control.

Prednicarbate CoA mostly includes findings from lab analyses of a specific batch. For each Prednicarbate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Prednicarbate may be tested according to a variety of international standards, such as European Pharmacopoeia (Prednicarbate EP), Prednicarbate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prednicarbate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty